SCHEMBL16179714

SCHEMBL16179714

O=C(Nc1ccc(O)c(C(=O)O)c1)c1cccc(NC(=O)c2ccco2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 1.00
▸ KMT2A Q03164 6/20 1.00
▸ SIRT6 Q8N6T7 3/20 1.00
▸ SIRT3 Q9NTG7 1/20 1.00
▸ POLB P06746 2/20 0.67
▸ ALDH1A1 P00352 2/20 0.67
▸ GAA P10253 2/20 0.67
▸ KCNK3 O14649 2/20 0.67
▸ KCNK9 Q9NPC2 2/20 0.67
▸ MAPT P10636 2/20 0.65
▸ ADRB2 P07550 1/20 0.65
▸ RAB9A P51151 1/20 0.64
▸ BLM P54132 1/20 0.64
▸ LMNA P02545 2/20 0.63
▸ MAPK1 P28482 1/20 0.63
▸ HTT P42858 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29564094 1.00 MEN1 (1.00) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL16179842 0.91 KMT2A (0.83) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL16179518 0.90 SIRT6 (1.00) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL13870855 0.84 MEN1 (0.72) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL13870838 0.83 ALDH1A1 (0.81) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL18906020 0.83 RAB9A (0.79) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL16179844 0.81 SIRT6 (1.00) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL3503699 0.81 GAA (1.00) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL6348632 0.80 MEN1 (0.69) MEN1KMT2ASIRT6SIRT3POLB
SCHEMBL1129948 0.79 KMT2A (0.77) MEN1KMT2ASIRT6SIRT3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014170873-A1 COMPOUNDS WITH A SIRTUIN INHIBITING ACTIVITY UNIVERSITÀ DEGLI STUDI DI GENOVA (IT) 2014-10-23 — — WO claimed
EP-4646195-A2 COMPOSITIONS AND METHODS FOR CONTROLLING GLUCOSE LEVELS Sirtsei Pharmaceuticals, Inc. (US) 2025-11-12 — — EP disclosed
EP-4637742-A1 COMPOSITIONS AND METHODS FOR TREATING ANHEDONIA Sirtsei Pharmaceuticals, Inc. (US) 2025-10-29 — — EP disclosed
US-20250114400-A1 Application of SIRT1-7 protein in immunotherapy Avenex Biosciences LTD. (CN) 2025-04-10 — — US disclosed
WO-2024168215-A1 COMPOSITIONS AND METHODS FOR TREATING ANHEDONIA SIRTSEI PHARACEUTICALS, INC. (US) 2024-08-15 — — WO disclosed
CN-116426483-B Application of CD258 protein in immunotherapy 南京紫珑生物科技有限公司 2024-02-23 — — CN disclosed
CN-116426483-A Application of CD258 protein in immunotherapy 南京紫珑生物科技有限公司 2023-07-14 — — CN disclosed
CN-116411025-A Application of SIRT1-7 protein in immunotherapy 南京紫珑生物科技有限公司 2023-07-11 — — CN disclosed
WO-2023123225-A1 APPLICATION OF SIRT1-7 PROTEIN IN IMMUNOTHERAPY 南京紫珑生物科技有限公司 2023-07-06 — — WO disclosed
WO-2023125945-A1 USE OF CD258 PROTEIN IN IMMUNOTHERAPY 南京紫珑生物科技有限公司 2023-07-06 — — WO disclosed
WO-2014170873-A1 COMPOUNDS WITH A SIRTUIN INHIBITING ACTIVITY UNIVERSITÀ DEGLI STUDI DI GENOVA (IT) 2014-10-23 — — WO disclosed
Send feedback